Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome

Tumori

Volumn 87, Issue 4, 2001, Pages

  Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN C;

CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; MORBIDITY; PERIOPERATIVE PERIOD; PERITONEUM PSEUDOMYXOMA; SURVIVAL RATE; SYNDROME;

EID: 0034804727     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700415     Document Type: Conference Paper

References (10)

1. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology
2. Pseudomyxoma peritonei: A cancer whose biology is characterized by a redistribution phenomenon
3. Peritonectomy procedures
4. Laser-mode electrosurgery
5. Intraperitoneal chemotherapy and cytoreductive surgery
6. Peritoneal carcinomatosis from appendiceal cancer: A paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy
7. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy
8. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis
9. Pseudomyxoma peritonei: New concepts in diagnosis, origin, nomenclature, relationship to mucinous borderline (low malignant potential) tumors of the ovary
10. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique